Literature DB >> 18268278

Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.

Ingmar Bruns1, Ulrich Steidl, Johannes C Fischer, Akos Czibere, Guido Kobbe, Sascha Raschke, Raminder Singh, Roland Fenk, Michael Rosskopf, Sabrina Pechtel, Arndt von Haeseler, Peter Wernet, Daniel G Tenen, Rainer Haas, Ralf Kronenwett.   

Abstract

BACKGROUND: Pegylated granulocyte colony-stimulating factor (G-CSF) has recently been introduced as a new compound for mobilization of CD34(+) hematopoietic stem and progenitor cells. In this study, we compared the molecular and functional characteristics of CD34(+) cells mobilized by pegylated G-CSF with those mobilized by unconjugated G-CSF. DESIGN AND METHODS: Gene expression of immunomagnetically enriched CD34(+) cells from leukapheresis products of patients who were given pegylated-G-CSF or unconjugated G-CSF was analyzed using Affymetrix HG Focus microarrays and quantitative reverse transcriptase polymerase chain reaction. Flow cytometry and fluorescence activated cell sorting was conducted to assess the CD34(+) subset composition and to obtain Lin(-), CD34(+), CD38(-) hematopoietic stem cells. Cell cycle assays and clonogenic assays were performed for functional corroboration.
RESULTS: Pegylated G-CSF and unconjugated G-CSF mobilized CD34(+) and hematopoietic stem cells with different molecular phenotypes and functional properties. The CD34(+) cells mobilized by pegylated G-CSF had higher expression levels of genes indicative of early hematopoiesis, including HOXA9, MEIS1 and GATA3. We found lower expression of genes characteristic of erythroid and later stages of myeloid differentiation and a lower functional burst-forming unit erythroid/colony-forming unit-granulocyte-macrophage ratio. Consistently, greater numbers of hematopoietic stem cells and common myeloid progenitors and fewer megakaryocyte-erthrocyte progenitors were found in the pegylated-G-CSF-mobilized CD34(+) cells. Additionally, sorted pegylated-G-CSF-mobilized hematopoietic stem cells displayed higher expression of HOXA9 in comparison to G-CSF-mobilized hematopoietic stem cells. In line with the gene expression data, CD34(+) cells mobilized by pegylated G-CSF, as well as sorted hematopoietic stem cells, showed a significantly greater cell cycle activity.
CONCLUSIONS: Stimulation with pegylated-G-CSF or G-CSF results in different expression of key regulatory genes and different functional properties of mobilized hematopoietic stem cells as well as their progeny, a finding that might be relevant for the application of these cells in blood stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268278     DOI: 10.3324/haematol.12081

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  9 in total

1.  Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease.

Authors:  Carlo Dufour; Barbara Cappelli; Michaela Calvillo; Francesca Fioredda; Rossella Tonelli; Roberto Crocchiolo
Journal:  Haematologica       Date:  2010-01-06       Impact factor: 9.941

Review 2.  Pegfilgrastim vs filgrastim in PBSC mobilization for autologous hematopoietic SCT: a systematic review and meta-analysis.

Authors:  M G Kim; N Han; E-K Lee; T Kim
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

3.  Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies.

Authors:  Giuseppina Bonanno; Annabella Procoli; Andrea Mariotti; Maria Corallo; Alessandro Perillo; Silvio Danese; Raimondo De Cristofaro; Giovanni Scambia; Sergio Rutella
Journal:  J Transl Med       Date:  2010-11-09       Impact factor: 5.531

4.  Specific activity of electron-beam synthesis immobilized hyaluronidase on G-CSF induced mobilization of bone marrow progenitor cells.

Authors:  A M Dygai; G N Zyuz'kov; V V Zhdanov; E V Udut; L A Miroshnichenko; E V Simanina; T Yu Khrichkova; M Yu Minakova; P G Madonov
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

5.  Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival.

Authors:  Akos Czibere; Ingmar Bruns; Bärbel Junge; Raminder Singh; Guido Kobbe; Rainer Haas; Ulrich Germing
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

6.  Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma.

Authors:  Matevz Skerget; Barbara Skopec; Darja Zontar; Peter Cernelc
Journal:  Radiol Oncol       Date:  2016-05-12       Impact factor: 2.991

7.  A comparison of the effect of xinruibai versus filgrastim on hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation.

Authors:  Qixiang Ye; Hebi Jiang; Hua Jiang
Journal:  Ital J Pediatr       Date:  2018-05-31       Impact factor: 2.638

8.  Allogeneic Hematopoietic Stem Cell Transplantation Mobilized With Pegylated Granulocyte Colony-Stimulating Factor Ameliorates Severe Acute Graft-Versus-Host Disease Through Enrichment of Monocytic Myeloid-Derived Suppressor Cells in the Graft: A Real World Experience.

Authors:  Lin Li; Jin Yin; Yun Li; Chunyan Wang; Xia Mao; Jia Wei; Yang Cao; Na Wang; Li Lin; Jinhuan Xu; Yicheng Zhang
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

9.  [Application of pegylated recombinant human granulocyte colony stimulating factor in mobilization of autologous peripheral blood stem cells].

Authors:  T Wang; R Feng; J T Li; S Y Ning; Y Z Yang; C L Zhang; J F Bai; H Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.